electroCore Announces Issuance of New Patent for Migraine Treatment using Smartphones
July 27, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, July 27, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the United States Patent and Trademark...
electroCore to Announce Second Quarter 2021 Financial Results on Thursday, August 5th
July 22, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, July 22, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the second...
electroCore announces Dr. Peter Staats to receive Lifetime Achievement Award from the American Society of Pain and Neuroscience
July 19, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, July 19, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its cofounder and Chief...
electroCore Provides Business Update and Select Second Quarter 2021 Financial Guidance
July 13, 2021 08:00 ET
|
electroCore, Inc.
Second-Quarter 2021 revenue expected to be approximately $1.3 millionNet cash used to fund operations in the second quarter 2021 of approximately $3.2 millionFollow on offering subsequent to June 30,...
electroCore to Participate in the Ladenburg Thalmann 2021 Virtual Healthcare Conference
July 09, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, July 09, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Dan Goldberger, CEO will present a company...
electroCore Announces Proposed Public Offering of Common Stock
June 29, 2021 16:01 ET
|
electroCore, Inc.
ROCKAWAY, NJ, June 29, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that it intends to offer and...
electroCore Announces Publication of Study on the Effect of non-invasive Vagus Nerve Stimulation (nVNS) on Cognitive Performance Caused by Sleep Deprivation
June 24, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, June 24, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a peer-reviewed paper on...
electroCore, Inc. Announces Exclusive Distribution Agreement with Kromax For Taiwan and China
June 23, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, June 23, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced it has entered into an agreement with Kromax...
electroCore to Join Russell Microcap® Index
June 16, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, June 16, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced today the addition of its stock to the broad-market...
electroCore Completes Sale of $1.4 Million of NJ NOL Tax Benefits
June 09, 2021 08:00 ET
|
electroCore, Inc.
ROCKAWAY, NJ, June 09, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it has completed the sale of $1.4 million of...